Medpace expands in the U.K.

Friday, August 14, 2015

Global CRO Medpace has relocated its existing U.K. office in Stirling, Scotland. The new office is roughly three times the size of the former facility, allowing for significant growth in data management, biostatistics, quality assurance, regulatory affairs, clinical operations and safety.

[Read More]

PSI, INC Research, Chiltern best with sites

Wednesday, April 1, 2015

Contract research organizations (CROs) have become more effective in managing working relationships with investigative sites during the past two years, according to a new CenterWatch survey, yet the average CRO continues to fall below performance expectations in many of the areas investigators consider most critical for study success.

[Read More]

Medpace opens new clinical pharmacology unit, expanding phase I-IIa capabilities

Thursday, July 19, 2012

Cincinnati-based Medpace has opened the Medpace Clinical Pharmacology Unit (CPU) in Cincinnati. The new 60,000-square-foot facility is double the size of the previous unit, increasing Medpace’s ability to conduct multiple studies with a total of 96 beds for overnight stays. The facility houses a pharmacy, processing labs and a dedicated patient recruitment staff for recruitment and screening of study subjects. The new CPU joins the Medpace global headquarters and the Medpace CRO.

[Read More]

Clinipace names VP, European clinical operations

Wednesday, November 2, 2011

Clinipace Worldwide has named Andrea Schiefer, Ph.D., vice president of European clinical operations and executive director of pharmacovigilance. In this position, Andrea reports directly to Kurt Pfister, chief executive officer of European operations at Clinipace Worldwide, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the European clinical operations unit at Clinipace Worldwide.

[Read More]